Zimmer is a leader in joint replacement solutions and provides comprehensive spine care solutions for acute and chronic back pain. The company also provides a broad range of trauma, dental implant and orthopaedic surgical products.
Zimmer’s dominance in reconstructive implants has drawn interest to a stock that’s been depressed in an industry that’s consolidating. Zimmer’s strong business franchise in orthopedics and solid financials make the company a particularly attractive acquisition for a large health care company looking to diversify its revenue base, according to the report.
Read the Daily Finance report on Zimmer’s investor attention.
Learn more about Zimmer Holdings.
